Emi H. Caywood, MD - Pediatric ...

Dr. Emi H. Caywood

Claim this profile

Alfred I duPont Hospital for Children

Expert in Adult T-Cell Leukemia/Lymphoma
Studies Acute Lymphoblastic Leukemia
23 reported clinical trials
63 drugs studied

About Emi H. Caywood

Education:

  • Earned an MD from the University of Medicine and Dentistry of New Jersey in 2002.
  • Completed a Residency in Pediatrics at Georgetown University Hospital in 2005.
  • Finished a Fellowship in Pediatric Hematology/Oncology at Johns Hopkins University in 2009.

Experience:

  • Board Certified in Pediatrics and Pediatric Hematology-Oncology.
  • Recognized as a Top Doctor by Delaware Today magazine in 2014 and a Hyundai Hope on Wheels Grant Scholar in 2008.
  • Specializes in treating children with cancers and blood disorders at Nemours Children's Health, Philadelphia, PA.

Area of expertise

1Adult T-Cell Leukemia/Lymphoma
Global Leader
Emi H. Caywood has run 12 trials for Adult T-Cell Leukemia/Lymphoma. Some of their research focus areas include:
BCR-ABL1 positive
Philadelphia chromosome positive
BCR-ABL1 T315I positive
2Acute Lymphoblastic Leukemia
Emi H. Caywood has run 10 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
BCR-ABL1 positive
Philadelphia chromosome positive
BCR-ABL1 T315I positive

Affiliated Hospitals

Image of trial facility.
Alfred I DuPont Hospital For Children
Image of trial facility.
Nemours Children's Clinic-Jacksonville

Clinical Trials Emi H. Caywood is currently running

Image of trial facility.

Non-TBI Conditioning

for HCT in Acute Lymphoblastic Leukemia

This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal residual disease) before receiving a hematopoietic cell transplant (HCT). Patients diagnosed with B-ALL who are candidates for HCT will be screened by NGS-MRD on a test of bone marrow done before the HCT. Subjects who are pre-HCT NGS-MRD negative will be eligible to receive a non-TBI conditioning regimen as part of the treatment cohort of the study. Subjects who are pre-HCT NGS-MRD positive will be treated as per treating center standard and will be followed in an observational cohort (HCT center standard of care).
Recruiting1 award Phase 2
Image of trial facility.

IST + BMT

for Aplastic Anemia

Severe Aplastic Anemia (SAA) is a rare condition in which the body stops producing enough new blood cells. SAA can be cured with immune suppressive therapy or a bone marrow transplant. Regular treatment for patients with aplastic anemia who have a matched sibling (brother or sister), or family donor is a bone marrow transplant. Patients without a matched family donor normally are treated with immune suppressive therapy (IST). Match unrelated donor (URD) bone marrow transplant (BMT) is used as a secondary treatment in patients who did not get better with IST, had their disease come back, or a new worse disease replaced it (like leukemia). This trial will compare time from randomization to failure of treatment or death from any cause of IST versus URD BMT when used as initial therapy to treat SAA. The trial will also assess whether health-related quality of life and early markers of fertility differ between those randomized to URD BMT or IST, as well as assess the presence of marrow failure-related genes and presence of gene mutations associated with MDS or leukemia and the change in gene signatures after treatment in both study arms. This study treatment does not include any investigational drugs. The medicines and procedures in this study are standard for treatment of SAA.
Recruiting2 awards Phase 3

More about Emi H. Caywood

Clinical Trial Related6 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Emi H. Caywood has experience with
  • Nivolumab
  • Cyclophosphamide
  • Etoposide
  • Dexamethasone
  • Methotrexate
  • Daunorubicin Hydrochloride

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Emi H. Caywood specialize in?
Is Emi H. Caywood currently recruiting for clinical trials?
Are there any treatments that Emi H. Caywood has studied deeply?
What is the best way to schedule an appointment with Emi H. Caywood?
What is the office address of Emi H. Caywood?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security